Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da95bf902d61571c90e56fc49f8f9ffe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4b0c317b8e0d5ef0731c4765a80a71f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d4e10d824f354b3e7e6a1b968d674d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-42 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-25 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-25 |
filingDate |
1999-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2763508231c4d56bbc36858ede9d49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f7cf0cf722085ed6e59f512fd2d7491 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd30f6711f886e1e1f723dde69ec2d83 |
publicationDate |
2000-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0032557-A1 |
titleOfInvention |
Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
abstract |
The invention concerns novel 3-alkoxybenzylamine derivatives of general formula (1) used as medicines in particular as antipsychotic drug. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6417222-B1 |
priorityDate |
1998-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |